Ayşegül Dumludağ

Dr. Ayşegül Dumludağ

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ATAlper Topal
Alper Topal
IEIsmail Erturk
Ismail Erturk
ÇKÇağlar Köseoğlu
Çağlar Köseoğlu
ADAyşegül Dumludağ
Ayşegül Dumludağ
ÖKömer Faruk Kuzu
ömer Faruk Kuzu
NKNuri Karadurmus
Nuri Karadurmus
Objective: Extragonadal germ cell tumours have a more unfavourable prognosis than gonadal germ cell tumours. We aimed to evaluate the survival analysis, response rates, and factors affecting responses to high-dose chemotherapy (HDCT) and autologous stem cell transplantation (ASCT) in patients with relapsed/refractory extragonadal germ cell tumours. Methods: This study included patients diagnosed with extragonadal germ cell tumours who underwent HDCT + ASCT between November 2016 and January 2023 at Gülhane Training and Research Hospital. Clinical characteristics and follow-up data from patient records and the hospital’s electronic system were retrospectively analysed. Patients under 18 years of age and those without medical records were excluded. Patient characteristics, post-HDCT progression-free survival (PFS), overall survival (OS) data, and factors affecting survival were examined. The relationship between clinical factors and OS/PFS was analysed. Results: Twenty-five patients were included in this study. Complete response (CR) was observed in seven patients (28%), partial response (PR) was observed in nine patients (36%), stable disease (SD) was observed in one patient, and progressive disease (PD) was observed in eight patients (32%) after HDCT + ASCT. The median follow-up period was 25.4 months. The median PFS and OS after HDCT + ASCT were calculated as 6.1 months and 12.2 months, respectively. Conclusions: Salvage HDCT + ASCT is an option in the treatment of extragonadal germ cell tumours, offering the potential for prolonged survival and curing.

9 April 2026 in Oncology Letters
Verified
Journal Article
Open access
PDF file
ADAyşegül Dumludağ
Ayşegül Dumludağ
MTMehmet Torun
Mehmet Torun
OSOsman Sütçüoğlu
Osman Sütçüoğlu
The C‑reactive protein‑triglyceride‑glucose index (CTI), integrating C‑reactive protein and the triglyceride‑glucose index, is a pragmatic biomarker reflecting systemic inflammation and metabolic stress in cancer. Although its prognostic value has been validated in heterogeneous cancer cohorts, data in homogeneous perioperative settings remain limited. The present study retrospectively evaluated 131 patients with locally advanced gastric or gastroesophageal junction adenocarcinoma who received perioperative fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) chemotherapy between November 2018 and June 2024 (67 months). CTI was calculated at diagnosis, and patients were stratified using the 4.78 cut‑off value previously validated in oncology populations. Associations between CTI and clinicopathological variables, pathological response, progression‑free survival (PFS) and overall survival (OS) were analyzed. The results demonstrated that among the 131 patients who underwent curative‑intent surgery after neoadjuvant FLOT, 113 (86.3%) had low CTI (<4.78) and 18 (13.7%) had high CTI (≥4.78). Patients with high CTI had significantly shorter PFS compared with those with low CTI (median, 12.2 vs. 25.5 months; P=0.006). OS was also markedly inferior in the high CTI group [median, 23.1 months vs. not reached (NR) in the low CTI group; P=0.001]. In the multivariable analysis, high CTI independently predicted poor PFS [hazard ratio (HR), 2.18; 95% confidence interval (CI), 1.21‑3.95; P=0.010]. Regarding treatment response, the pathological complete response rate was 11.5% (13/113) in the low CTI group and 22.2% (4/18) in the high CTI group (P=0.221), indicating no significant association between CTI and pathological complete response. In conclusion, pretreatment CTI is an independent prognostic marker in patients with locally advanced gastric or gastroesophageal junction adenocarcinoma treated with perioperative FLOT, identifying individuals at higher risk of relapse and inferior survival. The simplicity, low cost and pretherapeutic availability of pretreatment CTI support its use as a promising tool for risk stratification that warrants prospective, multicenter validation.

17 February 2026 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
ADAyşegül Dumludağ
Ayşegül Dumludağ
DÖDeniz Öcal
Deniz Öcal
MTMehmet Torun
Mehmet Torun
Background: Frailty has emerged as a critical determinant of postoperative morbidity, mortality, and survival in elderly cancer patients. However, evidence focusing specifically on octogenarian patients undergoing major gastrointestinal cancer surgery remains limited. Methods: This retrospective cohort study included 274 patients aged ≥ 80 years who underwent curative-intent colorectal or gastric cancer surgery at Erzurum City Hospital between 2015 and 2025. Patients were stratified into Low (0–1), Medium (2), and High (≥ 3) frailty groups using the modified Frailty Index-5 (mFI-5). Perioperative outcomes, adjuvant therapy feasibility, overall survival (OS), and recurrence-free survival (RFS) were evaluated and compared across frailty categories. Results: Of the 274 patients, 153 (55.8%) were classified as low frailty, 81 (29.6%) as medium frailty, and 40 (14.6%) as high frailty. Increasing frailty severity was associated with higher rates of major postoperative complications (12.5%, 27.8%, and 46.9%) and higher observed 90-day mortality (13.7%, 14.8%, and 37.5%). Median length of hospital stay differed across frailty groups and was 9.0 (IQR 6.0–12.0) days in Low frailty, 8.0 (IQR 6.0–12.0) days in Medium frailty, and 12.0 (IQR 8.0–15.0) days in High frailty patients. In multivariable analyses, high frailty was independently associated with higher 90-day major morbidity (adjusted OR 8.92, 95% CI 2.09–38.12; p = 0.003) and poorer OS (adjusted HR 3.70, 95% CI 1.88–7.28; p < 0.001). High frailty was also associated with poorer RFS in adjusted analyses (adjusted HR 3.85, 95% CI 1.41–10.50; p = 0.008). Conclusion: Preoperative frailty, as assessed by the mFI-5, is associated with increased perioperative morbidity and worse survival outcomes in octogenarian patients undergoing colorectal or gastric cancer surgery. Routine frailty assessment may support risk stratification and shared decision-making in this vulnerable population.

16 January 2026 in Genel Tıp Dergisi
Verified
Journal Article
Open access
ADAyşegül Dumludağ
Ayşegül Dumludağ
ATAlper Topal
Alper Topal
ETEsmanur Kaplan Tüzün
Esmanur Kaplan Tüzün
GYGizem Yıldırım
Gizem Yıldırım
BKBerkan Karadurmuş
Berkan Karadurmuş
NKNuri Karadurmuş
Nuri Karadurmuş
Aim: Metastatic osteosarcoma remains associated with poor survival despite multimodal therapy. High-dose chemotherapy followed by autologous stem cell transplantation (HDCT+ASCT) has been explored as a treatment intensification strategy; however, robust real-world data remain limited. This study aimed to evaluate treatment response and survival outcomes in patients with metastatic osteosarcoma treated with ICE-based HDCT followed by ASCT in a real-world setting.Materials and Methods: In this retrospective single-center cohort study, 46 patients with metastatic osteosarcoma who received ICE-based HDCT followed by ASCT were analyzed. Tumor response was assessed according to RECIST criteria. Progression-free survival (PFS) and overall survival (OS) were estimated using the Kaplan–Meier method. Univariable and multivariable Cox regression analyses were performed to evaluate associations between baseline clinical characteristics and survival outcomes.Results: The median age was 23,5 years, and 34 patients (73.9%) were male. The objective response rate (ORR) was 28.3%, and disease control (CR+PR+SD) was achieved in 52.2% of patients. Median PFS was 3.5 months (IQR: 2.6–6.0), and median OS was 10.7 months (IQR: 8.8–14.9). Survival curves demonstrated early attrition followed by a plateau phase. Exploratory analyses indicated longer OS in patients with ECOG 0–1 and lung-only metastases. No treatment-related mortality was observed.Conclusions: ICE-based HDCT followed by ASCT demonstrates measurable antitumor activity in metastatic osteosarcoma. However, given the limited median PFS and absence of a comparative control group, this approach should be considered a selective intensification strategy rather than a standard salvage therapy, and careful patient selection remains essential.

11 September 2025 in Medicina
Verified
Journal Article
Open access
PDF file
ÖKömer Faruk Kuzu
ömer Faruk Kuzu
NKNuri Karadurmuş
Nuri Karadurmuş
AAAhmet Gazi Acar
Ahmet Gazi Acar
NKNebi Batuhan Kanat
Nebi Batuhan Kanat
ÇKÇağlar Köseoğlu
Çağlar Köseoğlu
IEİsmail Ertürk
İsmail Ertürk
Background and Objectives: Relapsed or refractory germ cell tumors are commonly treated with HDCT/ASCT, but robust predictors of hematopoietic recovery are limited. Quantitative CT-based metrics of body composition are readily available, but their prognostic value for post-transplant engraftment remains uncertain. We investigated whether muscle and fat indices derived from routine CT scans are associated with the pace of hematologic recovery after HDCT/ASCT. Materials and Methods: This retrospective study analyzed a single-center cohort (n = 43) with relapsed/refractory GCT undergoing HDCT/ASCT. CT within 6 months pre-HDCT/ASCT was analyzed at L3 to derive the Skeletal muscle index, Psoas muscle index, Subcutaneous fat area, Visceral fat area, Total fat area, Visceral-to-subcutaneous fat area ratio. Primary endpoint: The engraftment time post-ASCT. Spearman’s ρ was used for univariable associations; multivariable linear regressions were adjusted for age, Hb, weight, and BSA to evaluate the independent effects. The significance was set at p < 0.05. Results: The median hematologic engraftment duration was 12.0 days, and the engraftment duration was positively correlated with age and negatively with hemoglobin. According to the multivariable analysis, older age and lower hemoglobin independently predicted longer engraftment; body weight and BSA were not significant. Among the morphometrics, only the VFA/SFA ratio was associated with delayed engraftment. The SMI, PMI, and TFA were not significant. As expected, after HDCT, grade 4 neutropenia and thrombocytopenia occurred in all patients. Conclusions: In relapsed/refractory GCT treated with HDCT/ASCT, older age and lower post-transplant hemoglobin independently predicted a prolonged engraftment. Beyond traditional muscle/fat areas, a higher VFA/SFA ratio—reflecting visceral adiposity—is also associated with delayed recovery, suggesting that fat distribution may influence hematopoietic regeneration. These variables may support pre-transplant risk stratification and individualized supportive care.

23 June 2025 in Turkish Journal of Gastroenterology
Verified
Journal Article
Open access
ADAyşegül Dumludağ
Ayşegül Dumludağ
MCMehmet Cindoruk
Mehmet Cindoruk
Background/Aims: Endoscopic ultrasound (EUS) has become an increasingly important tool in modern medicine, particularly in the diagnosis and treatment of pancreatic pathologies. The aim of this study is to elucidate the diagnostic and predictive roles of EUS in pancreatic cysts. Materials and Methods: Patients who underwent EUS for various clinical indications were retrospectively analyzed. Among them, the detailed characteristics of pancreatic cysts identified during the procedures were documented from the patients’ medical records. Results: A total of 1146 patients were included in the study, with a mean age of 56.4 years; 51.7% were female and 48.3% were male. Endoscopic ultrasound was primarily used to evaluate pancreatic lesions, focusing on cysts. Of a total of 200 pancreatic cysts evaluated pathologically, 74% (148) were benign, 24.5% (49) were malignant, and 1.5% (3) were borderline. No significant correlation was found between cyst size and malignancy (P = 1.00). However, malignancy rates significantly varied according to ultrasonographic characteristics, including simple cysts, mixed-type cysts (with solid components), pseudocysts, and infected cysts. The malignancy rate was significantly higher in mixed-type cysts (with solid components) (P = .0001). The presence of cyst-associated lymphadenopathy was also statistically significant for suspicion of malignancy (P = .005). Conclusion: This study highlights the importance of early diagnosis or surgical intervention for pancreatic cysts with mixed-type characteristics and associated lymph nodes. This underscores the need to prioritize triage for these patients. Cite this article as: Dumludağ A, Cindoruk M. Diagnostic and predictive features of pancreatic cysts using endoscopic ultrasound: A retrospective analysis from a single centre. Turk J Gastroenterol. 2025;36(12):852-857.